$AIMD
Ainos, Inc. Stock $aimd

$aimd Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000149315224018885 Filed on May 13, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue		$20.73K	$49.16K
YoY Change		-57.84%	-43.62%
Cost Of Revenue	$25.37K	$26.75K	$100.8K
YoY Change	-54.54%	-73.47%	145.5%
Gross Profit	-$25.37K	-$6.025K	-$51.68K
YoY Change	-6.93%	-88.34%	-212.06%
Gross Profit Margin		-29.07%	-105.13%
Selling, General & Admin	$1.045M	$1.029M	$762.5K
YoY Change	69.03%	35.01%	38.2%
% of Gross Profit
Research & Development	$1.979M	$2.085M	$1.699M
YoY Change	18.4%	22.71%	7.7%
% of Gross Profit
Depreciation & Amortization	$1.198M	$1.201M	$1.205M
YoY Change	-1.73%	-0.29%	3.07%
% of Gross Profit
Operating Expenses	$3.024M	$3.114M	$2.461M
YoY Change	32.07%	26.52%	15.6%
Operating Profit	-$3.049M	-$3.120M	-$2.513M
YoY Change	31.62%	24.16%	20.64%
Interest Expense	-$118.8K	$48.70K	$3.810K
YoY Change	258.48%	1178.11%	-76.01%
% of Operating Profit
Other Income/Expense, Net	-$146.0K	-$194.7K	$1.830K
YoY Change	-2133.61%	-10740.38%	1153.42%
Pretax Income	-$3.195M	-$3.315M	-$2.520M
YoY Change	35.97%	31.52%	20.03%
Income Tax
% Of Pretax Income
Net Earnings	-$3.195M	-$3.315M	-$2.520M
YoY Change	35.97%	31.52%	20.03%
Net Earnings / Revenue		-15991.17%	-5126.67%
Basic Earnings Per Share	-$0.49	-$0.57	-$0.63
Diluted Earnings Per Share	-$0.49	-$0.57	-$0.13
COMMON SHARES
Basic Shares Outstanding	6.284M shares	0.000 shares	20.01M shares
Diluted Shares Outstanding	6.519M shares	5.771M shares	4.002M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.014M	$1.031M	$1.146M
YoY Change	488.85%	-10.05%	-38.75%
Cash & Equivalents	$8.014M	$1.031M	$1.146M
Short-Term Investments
Other Short-Term Assets	$291.2K	$304.6K	$303.3K
YoY Change	20.7%	0.42%	-62.73%
Inventory	$166.3K	$169.7K	$572.4K
Prepaid Expenses
Receivables	$9.00	$4.172K	$111.3K
Other Receivables	$0.00	$0.00	$1.500M
Total Short-Term Assets	$8.472M	$1.509M	$3.633M
YoY Change	295.92%	-58.46%	20.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$691.1K	$768.7K	$1.315M
YoY Change	-45.55%	-41.53%	-7.39%
Goodwill
YoY Change
Intangibles	$26.03M	$27.16M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$348.6K	$320.9K	$68.82K
YoY Change	376.48%	366.26%	-13.55%
Total Long-Term Assets	$27.07M	$28.25M	$33.08M
YoY Change	-15.17%	-14.6%	-12.3%
TOTAL ASSETS
Total Short-Term Assets	$8.472M	$1.509M	$3.633M
Total Long-Term Assets	$27.07M	$28.25M	$33.08M
Total Assets	$35.54M	$29.75M	$36.71M
YoY Change	4.39%	-18.94%	-9.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$738.9K	$1.286M	$806.0K
YoY Change	72.05%	59.55%	-39.83%
Deferred Revenue
YoY Change
Short-Term Debt	$312.0K	$312.0K	$684.0K
YoY Change	-54.39%	-54.39%	-32.51%
Long-Term Debt Due	$4.586M	$3.000M	$376.5K
YoY Change		696.75%	-88.85%
Total Short-Term Liabilities	$5.743M	$4.706M	$1.867M
YoY Change	415.78%	152.12%	-67.42%
LONG-TERM LIABILITIES
Long-Term Debt	$9.000M	$2.370M	$2.500M
YoY Change	260.0%	-5.21%	-90.71%
Other Long-Term Liabilities	$83.91K		$3.280K
YoY Change	123.4%		-86.42%
Total Long-Term Liabilities	$83.91K	$0.00	$2.503M
YoY Change	123.4%	-100.0%	-90.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.743M	$4.706M	$1.867M
Total Long-Term Liabilities	$83.91K	$0.00	$2.503M
Total Liabilities	$14.83M	$7.076M	$4.370M
YoY Change	306.1%	61.92%	-86.62%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.40M	-$41.20M	-$26.64M
YoY Change	53.16%	54.68%	118.17%
Common Stock	$1.318M	$1.528M	$200.1K
YoY Change	549.52%	663.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.71M	$22.68M	$32.34M
YoY Change
Total Liabilities & Shareholders Equity	$35.54M	$29.75M	$36.71M
YoY Change	4.39%	-18.94%	-9.89%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	-$3.195M	-$3.315M	-$2.520M
YoY Change	35.97%	31.52%	20.03%
Depreciation, Depletion And Amortization	$1.198M	$1.201M	$1.205M
YoY Change	-1.73%	-0.29%	3.07%
Cash From Operating Activities	-$1.974M	-$1.495M	-$1.427M
YoY Change	71.51%	4.72%	2.7%
INVESTING ACTIVITIES
Capital Expenditures	$5.850K	$4.428K	$72.18K
YoY Change	-735.87%	-93.87%	-46.88%
Acquisitions
YoY Change
Other Investing Activities	-$2.670K	-$106.9K	-$300.00
YoY Change		35516.67%	-99.78%
Cash From Investing Activities	-$8.510K	-$111.3K	-$72.48K
YoY Change	-797.54%	53.53%	-46.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	9.000M	$777.5K	$795.2K
YoY Change	547.12%	-2.23%	-51.66%
NET CHANGE
Cash From Operating Activities	-1.974M	-$1.495M	-$1.427M
Cash From Investing Activities	-8.510K	-$111.3K	-$72.48K
Cash From Financing Activities	9.000M	$777.5K	$795.2K
Net Change In Cash	7.017M	-$854.7K	-$707.2K
YoY Change	2812.13%	20.86%	-693.83%
FREE CASH FLOW
Cash From Operating Activities	-$1.974M	-$1.495M	-$1.427M
Capital Expenditures	$5.850K	$4.428K	$72.18K
Free Cash Flow	-$1.980M	-$1.499M	-$1.500M
YoY Change	72.16%	-0.03%	-1.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2024Q1	AIMD	Other Notes Payable Related Party Noncurrent OtherNotesPayableRelatedPartyNoncurrent		usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2024Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2024Q1	AIMD	Other Notes Payable Related Party Noncurrent OtherNotesPayableRelatedPartyNoncurrent		usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2023Q1	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2023Q1	AIMD	Change In Fair Value Of Senior Secured Convertible Note Measured At Fair Value ChangeInFairValueOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable		usd
CY2024Q1	AIMD	Repayment Of Other Notes Payable Related Party RepaymentOfOtherNotesPayableRelatedParty		usd
CY2024Q1	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q1	AIMD	Payable For Purchase Of Equipment PayableForPurchaseOfEquipment		usd
CY2024Q1	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues		usd
CY2024Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41461
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-1974352
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8880 Rio San Diego Drive
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 800
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92108
CY2024Q1	dei	City Area Code CityAreaCode	(858)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	869-2986
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6284300	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2023Q1	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote		usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross		usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2023Q1	AIMD	Change In Fair Value Of Senior Secured Convertible Note Measured At Fair Value ChangeInFairValueOfSeniorSecuredConvertibleNoteMeasuredAtFairValue		usd
CY2024Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2023Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable		usd
CY2024Q1	AIMD	Repayment Of Other Notes Payable Related Party RepaymentOfOtherNotesPayableRelatedParty		usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2024Q1	us-gaap	Notes Issued1 NotesIssued1		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
CY2024Q1	AIMD	Payable For Purchase Of Equipment PayableForPurchaseOfEquipment		usd
CY2024Q1	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues		usd
CY2024Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense		usd
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-41461
CY2024Q1	dei	Entity Registrant Name EntityRegistrantName	AINOS, INC.
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	75-1974352
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	8880 Rio San Diego Drive
CY2024Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Ste. 800
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Diego
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92108
CY2024Q1	dei	City Area Code CityAreaCode	(858)
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	869-2986
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6284300	shares
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4172	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	455	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	169655	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	167593	usd
CY2024Q1	us-gaap	Other Assets Current OtherAssetsCurrent	304608	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	419521	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	1509334	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2473197	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27155594	usd
CY2024Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	312000	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	42000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1285973	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1182283	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4705973	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1336838	usd
CY2024Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2369694	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3000000	usd
CY2023Q4	AIMD	Other Notes Payable Related Party Noncurrent OtherNotesPayableRelatedPartyNoncurrent	270000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	135829	usd
CY2024Q1	us-gaap	Liabilities Liabilities	7075667	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7394223	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6144506	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4677787	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4677787	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	61445	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	46778	usd
CY2024Q1	AIMD	Shares Obligated To Issue SharesObligatedToIssue	270	shares
CY2023Q4	AIMD	Shares Obligated To Issue SharesObligatedToIssue	162337	shares
CY2024Q1	AIMD	Common Stock Issuable CommonStockIssuable	3	usd
CY2023Q4	AIMD	Common Stock Issuable CommonStockIssuable	1623	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64154052	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62555808	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41200965	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-37886155	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-335742	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270473	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	22678793	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24447581	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29754460	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	876572	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	320867	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	208827	usd
CY2024Q1	us-gaap	Assets Assets	29754460	usd
CY2023Q4	us-gaap	Assets Assets	31841804	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	108000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	112555	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3000000	usd
CY2024Q1	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3000000	usd
CY2024Q1	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	312000	usd
CY2023Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	42000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1285973	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1182283	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4705973	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1336838	usd
CY2024Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2369694	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3000000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	135829	usd
CY2024Q1	us-gaap	Liabilities Liabilities	7075667	usd
CY2023Q4	us-gaap	Liabilities Liabilities	7394223	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6144506	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6144506	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4677787	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4677787	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	61445	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	46778	usd
CY2024Q1	AIMD	Shares Obligated To Issue SharesObligatedToIssue	270	shares
CY2023Q4	AIMD	Shares Obligated To Issue SharesObligatedToIssue	162337	shares
CY2024Q1	AIMD	Common Stock Issuable CommonStockIssuable	3	usd
CY2023Q4	AIMD	Common Stock Issuable CommonStockIssuable	1623	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	64154052	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	62555808	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41200965	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-335742	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-270473	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	22678793	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24447581	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	29754460	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31841804	usd
CY2024Q1	us-gaap	Revenues Revenues	20729	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	31841804	usd
CY2024Q1	us-gaap	Revenues Revenues	20729	usd
CY2023Q1	us-gaap	Revenues Revenues	49164	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	26754	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	100848	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-6025	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-51684	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2084648	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	762465	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3114066	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2461348	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3120091	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2513032	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	48696	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9273	usd
CY2024Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2024Q1	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-31568	usd
CY2024Q1	us-gaap	Other Income OtherIncome	24537	usd
CY2023Q1	us-gaap	Other Income OtherIncome	1830	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-194719	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7443	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3314810	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2520475	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3314810	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5771283	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5771283	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4002210	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4002210	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	65269	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-10061	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3380079	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2510414	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	24447581	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1188430	usd
CY2024Q1	AIMD	Adjustments To Additional Paid In Capital Related Party Used Computer Equipment Amount AdjustmentsToAdditionalPaidInCapitalRelatedPartyUsedComputerEquipmentAmount	-4428	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1586	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-65269	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	22678793	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34628006	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	220832	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	10061	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	32338424	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1201109	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1204609	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	42826	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	425703	usd
CY2023Q1	us-gaap	Revenues Revenues	49164	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	26754	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	100848	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	-6025	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	-51684	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2084648	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1698883	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1029418	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	762465	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	3114066	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2461348	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3120091	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2513032	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	48696	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	9273	usd
CY2024Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2024Q1	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-31568	usd
CY2024Q1	us-gaap	Other Income OtherIncome	24537	usd
CY2023Q1	us-gaap	Other Income OtherIncome	1830	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-194719	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7443	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3314810	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2520475	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3314810	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5771283	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5771283	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4002210	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4002210	shares
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3314810	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	65269	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest	-10061	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2510414	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1188430	usd
CY2024Q1	AIMD	Adjustments To Additional Paid In Capital Related Party Used Computer Equipment Amount AdjustmentsToAdditionalPaidInCapitalRelatedPartyUsedComputerEquipmentAmount	-4428	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1586	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	425703	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-65269	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	34628006	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	220832	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3314810	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1201109	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1204609	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	42826	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	425703	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	220832	usd
CY2024Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2024Q1	AIMD	Change In Fair Value Of Senior Secured Convertible Note Measured At Fair Value ChangeInFairValueOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	31568	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3717	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-90263	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2062	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19948	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-114913	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	107531	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-86443	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-342805	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1494747	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1432229	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4428	usd
CY2024Q1	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets	106852	usd
CY2023Q1	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets	299	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-111280	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72483	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	usd
CY2024Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	875000	usd
CY2023Q1	AIMD	Repayment Of Other Notes Payable Related Party RepaymentOfOtherNotesPayableRelatedParty	200000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	97500	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	777500	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	800000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2518	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-854729	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1853362	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1030899	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1146132	usd
CY2023Q1	us-gaap	Notes Issued1 NotesIssued1	1500000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1188430	usd
CY2023Q1	AIMD	Payable For Purchase Of Equipment PayableForPurchaseOfEquipment	5848	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	220832	usd
CY2024Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2024Q1	AIMD	Change In Fair Value Of Senior Secured Convertible Note Measured At Fair Value ChangeInFairValueOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	31568	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3717	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-90263	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	2062	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	19948	usd
CY2024Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-114913	usd
CY2023Q1	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	107531	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-86443	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-342805	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1494747	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1432229	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4428	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	72184	usd
CY2024Q1	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets	106852	usd
CY2023Q1	AIMD	Increase In Refundable Deposits And Other Assets IncreaseInRefundableDepositsAndOtherAssets	299	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-111280	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-72483	usd
CY2023Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1000000	usd
CY2024Q1	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	875000	usd
CY2023Q1	AIMD	Repayment Of Other Notes Payable Related Party RepaymentOfOtherNotesPayableRelatedParty	200000	usd
CY2024Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	97500	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	777500	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	800000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-26202	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-2518	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-854729	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-707230	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1885628	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1853362	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1030899	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1146132	usd
CY2023Q1	us-gaap	Notes Issued1 NotesIssued1	1500000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1188430	usd
CY2023Q1	AIMD	Payable For Purchase Of Equipment PayableForPurchaseOfEquipment	5848	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1030899	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3314810	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41200965	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84B_eus-gaap--UseOfEstimates_zVJYxbs7tvkf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"><b><span id="xdx_867_zIqwlRyrSTn2">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The preparation of condensed financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities and disclosures as of the date of the condensed financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on various factors, including historical experience, and on various other assumptions that are believed to be reasonable under the circumstances, when these carrying values are not readily available from other sources. Significant items subject to estimates and assumptions include useful lives of property and equipment, valuation of stock option, warrants and convertible notes measured at fair value, and impairment testing of intangible assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1030899	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3314810	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41200965	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	524108	usd
CY2023Q4	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	1557487	usd
CY2024Q1	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	3000000	twd
CY2024Q1	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	93750	usd
CY2024Q1	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	104164	twd
CY2023Q4	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	0	twd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	88271	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	92708	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1158	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1208	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	80226	usd
CY2024Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2024Q1	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	524108	usd
CY2023Q4	AIMD	Excess Of Fdic Insured Limits ExcessOfFdicInsuredLimits	1557487	usd
CY2024Q1	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	3000000	twd
CY2024Q1	AIMD	Cash Cdic Insured Amount CashCDICInsuredAmount	93750	usd
CY2024Q1	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	104164	twd
CY2023Q4	AIMD	Excess Of Cdic Insured Limits ExcessOfCDICInsuredLimits	0	twd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	88271	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	92708	usd
CY2024Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1158	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1208	usd
CY2024Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	80226	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	169655	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	167593	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	73677	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	169655	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	167593	usd
CY2023Q1	AIMD	Inventory Writedowns Net Realizable Values InventoryWritedownsNetRealizableValues	42780	usd
CY2024Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2369694	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2651556	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	5681694	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	5963556	usd
CY2024Q1	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-31568	usd
CY2024Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4430732	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1409810	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	894444	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	0	shares
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y18D
CY2024Q1	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2369694	usd
CY2023Q4	us-gaap	Convertible Debt Fair Value Disclosures ConvertibleDebtFairValueDisclosures	2651556	usd
CY2024Q1	us-gaap	Notes Payable NotesPayable	5681694	usd
CY2023Q4	us-gaap	Notes Payable NotesPayable	5963556	usd
CY2024Q1	AIMD	Fair Value Change Of Senior Secured Convertible Note FairValueChangeOfSeniorSecuredConvertibleNote	-31568	usd
CY2024Q1	AIMD	Issurance Cost Of Senior Secured Convertible Note Measured At Fair Value IssuranceCostOfSeniorSecuredConvertibleNoteMeasuredAtFairValue	-138992	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1466719	usd
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6144506	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6144506	shares
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	4430732	shares
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1409810	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	894444	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations	0	shares
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	108000	usd
CY2023Q2	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	871075	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7332	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5111	shares
CY2024Q1	AIMD	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAndExercisableNumber	6034	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	425703	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	220832	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2927017	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	108000	usd
CY2023Q2	us-gaap	Employee Stock Ownership Plan Esop Shares In Esop EmployeeStockOwnershipPlanESOPSharesInESOP	871075	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7332	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	5111	shares
CY2024Q1	AIMD	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestAndExercisableNumber	6034	shares
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	425703	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	220832	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	2927017	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y18D
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5771283	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	5771283	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4002210	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4002210	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-3314810	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2520475	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5771283	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	5771283	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4002210	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4002210	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.57
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.57
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.63
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.63
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5254221	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	721633	shares
CY2024Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	118710	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	87632	usd
CY2023Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	19726	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5254221	shares
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	721633	shares
CY2024Q1	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	118710	usd
CY2023Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	87632	usd
CY2023Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	19726	usd

Files In Submission

Name	View Source	Status
0001493152-24-018885-index-headers.html	Edgar Link	pending
0001493152-24-018885-index.html	Edgar Link	pending
0001493152-24-018885.txt	Edgar Link	pending
0001493152-24-018885-xbrl.zip	Edgar Link	pending
aimd-20240331.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
aimd-20240331_cal.xml	Edgar Link	unprocessable
aimd-20240331_def.xml	Edgar Link	unprocessable
aimd-20240331_lab.xml	Edgar Link	unprocessable
aimd-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AIMD
Ainos, Inc. Stock $aimd

2024 Q2 Form 10-Q Financial Statement

#000149315224018885 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD Ainos, Inc. Stock $aimd

2024 Q2 Form 10-Q Financial Statement

#000149315224018885 Filed on May 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AIMD
Ainos, Inc. Stock $aimd